Tags: canada + multiple sclerosis.with.MS
Sort by: Date /
Title /
URL
-
Shares of BioMS Medical Corp (MS.TO: Quote) plunged 90 percent on Tuesday after the company and Eli Lilly and Co (LLY.N: Quote) said their multiple sclerosis treatment failed to delay the progression of the disease in a late-stage trial.
-
Information about employment rights in Canada (and a lively discussion)
-
The vaccine incorporates the sequence of myelin basic protein (MBP), which is thought to be one of the targets of MS, and DNA is incorporated into the cells in the body, which then starts to make the protein.
-
A few weeks ago, though, Ms. Myrden's lustre was lessened after she was denied a summer student - one of five hired to give companionship to MS sufferers - by the Burlington chapter of the Multiple Sclerosis Society of Canada.
-
his year, Dr. Mark Freedman discusses the latest in MS research, progress in the bone marrow transplantation study and takes questions from callers.
-
Two Ottawa researchers have been awarded a $2.4-million grant for their work in fighting multiple sclerosis, a chronic and often disabling disease of the brain and spinal cord.
-
Anatole Otis, 67, has suffered from multiple sclerosis for more than a decade, but was diagnosed as demented when he first sought medical attention.
-
Senior defenseman Mike Campaner (Thunder Bay, Ont.) of the Colgate University men's hockey team made public today that he suffers from multiple sclerosis, an auto-immune disease that affects the central nervous system. Campaner was diagnosed with MS in D
-
he husband of a Nova Scotia woman who died at an assisted-suicide clinic in Switzerland this month said yesterday he doesn't fear a police investigation into the matter and doesn't expect charges to be laid against him.
-
The neurologists called for new priorities in health care, saying billions could be saved through earlier diagnoses, stroke prevention programs and Alzheimer's research.
-
The cost of MS to the Canadian economy is estimated to be more than $1 billion per year.
-
BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), is pleased to announce Dr. Clyde E. Markowitz as the lead investigator in the United States for the Company’s pivotal phase III clinical trial of its lead dru
-
I've become this (self-proclaimed) posterchild for MS. I have been open about it. I've been okay with it.
-
While multiple sclerosis has made some regular everyday activities difficult for a Bolton woman, she considers herself very fortunate she can still do most everything she wants.
-
His wife was diagnosed with multiple sclerosis in 1998, but he says that her condition has "stopped in its tracks" and is "not much of a factor in our lives."
First / Previous / Next / Last / Page 1 of 5